We further examined whether acute tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist recently approved by the FDA for obesity, and retatrutide, an investigational triple agonist targeting GIP, GLP-1, and glucagon receptors currently in Phase 3 trials would recapitulate or enhance these effects
This means guiding members toward clinically effective drugs that may have lower prices or better net economics for the plan
Long term, well get more information, but right now it looks like we have enough information that were not really seeing a significant effect on the fetus, only improvement because we have better glycemic control prior to pregnancy.
And oral HRT is one of the most commonly prescribed hormone delivery methods
So does the number of people who want to understand exactly what they are signing up for before they commit - which medications are described within the program, whether insurance covers them, how pricing is structured, and how these telehealth platforms work behind the scenes